Liquid Biopsy, an Everchanging Balance between Clinical Utility and Emerging Technologies

por Cucciniello, Linda, Gerratana, Lorenzo, Puglisi, Fabio
Publicado 2022

Editorial: Cancer evolution: From biological insights to therapeutic opportunities

por Davis, Andrew A., Gerratana, Lorenzo, Mina, Marco
Publicado 2022

The puzzling clinical presentation of fluoropyrimidines cardiotoxicity

por Cucciniello, Linda, Bidoli, Ettore, Viel, Elda, Canale, Maria Laura, Gerratana, Lorenzo, Lestuzzi, Chiara
Publicado 2022

Platinum Salts in Patients with Breast Cancer: A Focus on Predictive Factors

por Garutti, Mattia, Pelizzari, Giacomo, Bartoletti, Michele, Malfatti, Matilde Clarissa, Gerratana, Lorenzo, Tell, Gianluca, Puglisi, Fabio
Publicado 2019

Editorial: Altered expression of proteins in cancer: function and potential therapeutic targets, volume II

por Pessoa, João, Valenti, Maria Teresa, Bellance, Nadège, Chiarella, Paula, Abebe, Tamrat, Gerratana, Lorenzo, Pérez-Plasencia, Carlos, Kzhyshkowska, Julia
Publicado 2023

Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example

por Gerratana, Lorenzo, De Maglio, Giovanna, De Pellegrin, Alessandro, Follador, Alessandro, Rihawi, Karim, Pizzolitto, Stefano, Puglisi, Fabio, Fasola, Gianpiero
Publicado 2016

APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC

por Malfatti, Matilde Clarissa, Gerratana, Lorenzo, Dalla, Emiliano, Isola, Miriam, Damante, Giuseppe, Di Loreto, Carla, Puglisi, Fabio, Tell, Gianluca
Publicado 2019

Image Analysis of Circulating Tumor Cells and Leukocytes Predicts Survival and Metastatic Pattern in Breast Cancer Patients

por Da Col, Giacomo, Del Ben, Fabio, Bulfoni, Michela, Turetta, Matteo, Gerratana, Lorenzo, Bertozzi, Serena, Beltrami, Antonio Paolo, Cesselli, Daniela
Publicado 2022

Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis

por Bartoletti, Michele, Pelizzari, Giacomo, Gerratana, Lorenzo, Bortot, Lucia, Lombardi, Davide, Nicoloso, Milena, Scalone, Simona, Giorda, Giorgio, Baldassarre, Gustavo, Sorio, Roberto, Puglisi, Fabio
Publicado 2020

Single-Cells Isolation and Molecular Analysis: Focus on HER2-Low CTCs in Metastatic Breast Cancer

por D’Amico, Paolo, Reduzzi, Carolina, Qiang, Wenan, Zhang, Youbin, Gerratana, Lorenzo, Zhang, Qiang, Davis, Andrew A., Shah, Ami N., Manai, Maroua, Curigliano, Giuseppe, Cristofanilli, Massimo
Publicado 2021

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer

por Davis, Andrew A., Zhang, Qiang, Gerratana, Lorenzo, Shah, Ami N., Zhan, Youbin, Qiang, Wenan, Finkelman, Brian S., Flaum, Lisa, Behdad, Amir, Gradishar, William J., Platanias, Leonidas C., Cristofanilli, Massimo
Publicado 2019

Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside

por Basile, Debora, Di Nardo, Paola, Corvaja, Carla, Garattini, Silvio Ken, Pelizzari, Giacomo, Lisanti, Camilla, Bortot, Lucia, Da Ros, Lucia, Bartoletti, Michele, Borghi, Matteo, Gerratana, Lorenzo, Lombardi, Davide, Puglisi, Fabio
Publicado 2019

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers

por Shah, Ami N., Sunderraj, Ashwin, Finkelman, Brian, See, Sharlene H., Davis, Andrew A., Gerratana, Lorenzo, Wehbe, Firas, Katam, Neelima, Mahalingam, Deva, Gradishar, William J., Behdad, Amir, Blanco, Luis, Cristofanilli, Massimo
Publicado 2022

Landscape of circulating tumour DNA in metastatic breast cancer

por Davis, Andrew A., Jacob, Saya, Gerratana, Lorenzo, Shah, Ami N., Wehbe, Firas, Katam, Neelima, Zhang, Qiang, Flaum, Lisa, Siziopikou, Kalliopi P., Platanias, Leonidas C., Gradishar, William J., Behdad, Amir, Cristofanilli, Massimo
Publicado 2020

In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis

por Bulfoni, Michela, Gerratana, Lorenzo, Del Ben, Fabio, Marzinotto, Stefania, Sorrentino, Marisa, Turetta, Matteo, Scoles, Giacinto, Toffoletto, Barbara, Isola, Miriam, Beltrami, Carlo Alberto, Di Loreto, Carla, Beltrami, Antonio Paolo, Puglisi, Fabio, Cesselli, Daniela
Publicado 2016

An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer

por Roncato, Rossana, Gerratana, Lorenzo, Palmero, Lorenza, Gagno, Sara, Poetto, Ariana Soledad, Peruzzi, Elena, Zanchetta, Martina, Posocco, Bianca, De Mattia, Elena, Canil, Giovanni, Alberti, Martina, Orleni, Marco, Toffoli, Giuseppe, Puglisi, Fabio, Cecchin, Erika
Publicado 2022

Role of Bruton’s Tyrosine Kinase in Stage III Colorectal Cancer

por Basile, Debora, Gerratana, Lorenzo, Buonadonna, Angela, Garattini, Silvio Ken, Perin, Tiziana, Grassilli, Emanuela, Miolo, Gianmaria, Cerrito, Maria Grazia, Belluco, Claudio, Bertola, Giulio, De Paoli, Antonino, Cannizzaro, Renato, Lavitrano, Marialuisa, Puglisi, Fabio, Canzonieri, Vincenzo
Publicado 2019

KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC

por Cinausero, Marika, Laprovitera, Noemi, De Maglio, Giovanna, Gerratana, Lorenzo, Riefolo, Mattia, Macerelli, Marianna, Fiorentino, Michelangelo, Porcellini, Elisa, Buoro, Vanessa, Gelsomino, Francesco, Squadrilli, Anna, Fasola, Gianpiero, Negrini, Massimo, Tiseo, Marcello, Ferracin, Manuela, Ardizzoni, Andrea
Publicado 2019

Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis

por De Angelis, Carmine, Di Maio, Massimo, Crispo, Anna, Giuliano, Mario, Schettini, Francesco, Bonotto, Marta, Gerratana, Lorenzo, Iacono, Donatella, Cinausero, Marika, Riccardi, Ferdinando, Ciancia, Giuseppe, De Laurentiis, Michelino, Puglisi, Fabio, De Placido, Sabino, Arpino, Grazia
Publicado 2017

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer

por Gerratana, Lorenzo, Basile, Debora, Franzoni, Alessandra, Allegri, Lorenzo, Viotto, Davide, Corvaja, Carla, Bortot, Lucia, Bertoli, Elisa, Buriolla, Silvia, Targato, Giada, Da Ros, Lucia, Russo, Stefania, Bonotto, Marta, Belletti, Barbara, Baldassarre, Gustavo, Damante, Giuseppe, Puglisi, Fabio
Publicado 2020